{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:25:33Z","timestamp":1793899533208,"version":"4.8.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND:<\/jats:title>\n            <jats:p>Hypertension frequently accompanies chronic kidney disease (CKD) as etiology and sequela. We examined contemporary trends in hypertension treatment and control in a national sample of adults with CKD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS:<\/jats:title>\n            <jats:p>\n              We evaluated 5% cross-sectional samples of adults with CKD between 2011 and 2019 in the Veterans Health Administration. We defined CKD as a sustained estimated glomerular filtration rate value &lt;60 mL\/min per 1.73 m\n              <jats:sup>2<\/jats:sup>\n              or a urine albumin-to-creatinine ratio \u226530 mg\/g. The main outcomes were blood pressure (BP) control, defined as a systolic BP &lt;140 mm\u2009Hg and a diastolic BP &lt;90 mm\u2009Hg based on the mean of monthly BP measurements, and prescriptions for antihypertensive medications.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>\n              The annual samples ranged between n=22\u2005110 and n=33\u2005039 individuals, with a mean age of 72 years, 96% of whom were men. Between 2011 and 2014, the age-adjusted proportion of adults with controlled BP declined from 78.0% to 72.2% (\n              <jats:italic toggle=\"yes\">P<\/jats:italic>\n              value for linear trend, &lt;0.001), reached a nadir of 71.0% in 2015, and then increased to 72.9% by 2019 (\n              <jats:italic toggle=\"yes\">P<\/jats:italic>\n              value for linear trend, &lt;0.001). Among adults with BP above goal, the age-adjusted proportion who did not receive antihypertensive treatment increased throughout the decade from 18.8% to 21.6%, and the age-adjusted proportion who received \u22653 antihypertensive medications decreased from 41.8% to 36.3%. Prescriptions for first-line antihypertensive agents also decreased.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>Among adults with CKD treated in the Veterans Health Administration, the proportion with controlled BP declined between 2011 and 2015 followed by a modest increase, coinciding with fewer prescriptions for antihypertensive medications.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/hypertensionaha.123.21523","type":"journal-article","created":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T14:26:10Z","timestamp":1694701570000},"page":"2533-2543","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Treatment and Control of Hypertension Among Adults With Chronic Kidney Disease, 2011 to 2019"],"prefix":"10.1161","volume":"80","author":[{"given":"Joshua D.","family":"Martinez","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Stanford University School of Medicine and VA Palo Alto Health Care System, CA (J.D.M., M.E.M.-R., A.C.P., M.K.T.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Chun","family":"Thomas","sequence":"additional","affiliation":[{"name":"Geriatric Research and Education Clinical Center, VA Palo Alto Health Care System, CA (I.-C.T., M.C.O., M.K.T.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5154-2182","authenticated-orcid":true,"given":"Maria E.","family":"Montez-Rath","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Stanford University School of Medicine and VA Palo Alto Health Care System, CA (J.D.M., M.E.M.-R., A.C.P., M.K.T.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan C.","family":"Pao","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Stanford University School of Medicine and VA Palo Alto Health Care System, CA (J.D.M., M.E.M.-R., A.C.P., M.K.T.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8485-3972","authenticated-orcid":true,"given":"Enrica","family":"Fung","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Loma Linda University School of Medicine and Loma Linda VA Health Care System, CA (E.F.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7147-9026","authenticated-orcid":true,"given":"Vivek","family":"Charu","sequence":"additional","affiliation":[{"name":"Quantitative Sciences Unit, Department of Medicine (V.C.), Stanford University School of Medicine, CA."},{"name":"Department of Pathology (V.C.), Stanford University School of Medicine, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9456-8243","authenticated-orcid":true,"given":"John J.","family":"Sim","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA (J.J.S., J.A.)."},{"name":"Department of Medicine, Division of Nephrology and Hypertension, Kaiser Permanente Los Angeles Medical Center, CA (J.J.S.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3161-5732","authenticated-orcid":true,"given":"Jaejin","family":"An","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA (J.J.S., J.A.)."},{"name":"Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA (J.A.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5974-3648","authenticated-orcid":true,"given":"Michelle C.","family":"Odden","sequence":"additional","affiliation":[{"name":"Geriatric Research and Education Clinical Center, VA Palo Alto Health Care System, CA (I.-C.T., M.C.O., M.K.T.)."},{"name":"Department of Epidemiology and Population Health (M.C.O.), Stanford University School of Medicine, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5227-2479","authenticated-orcid":true,"given":"Manjula","family":"Kurella Tamura","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Stanford University School of Medicine and VA Palo Alto Health Care System, CA (J.D.M., M.E.M.-R., A.C.P., M.K.T.)."},{"name":"Geriatric Research and Education Clinical Center, VA Palo Alto Health Care System, CA (I.-C.T., M.C.O., M.K.T.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","volume-title":"Centers for Disease Control and Prevention","author":"Centers for Disease Control and Prevention","year":"2021","unstructured":"Centers for Disease Control and Prevention. Chronic kidney disease in the United States, 2021. Centers for Disease Control and Prevention. US Department of Health and Human Services; 2021."},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041031"},{"key":"e_1_3_3_4_2","volume-title":"Veterans Health Administration, Department of Veterans Affairs, and Health Affairs, Department of Defense","year":"2020","unstructured":"VA\/DoD Clinical Practice Guideline for the Management of Hypertension in Primary Care. Veterans Health Administration, Department of Veterans Affairs, and Health Affairs, Department of Defense. Department of Veterans Affairs. 2020."},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.10.026"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYP.0000000000000066"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.14545"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.122.19222"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.284427"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.27014"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-11-201306040-00007"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2102953"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.029983"},{"key":"e_1_3_3_14_2","volume-title":"VA\/DoD Clinical Practice Guideline for the Management of Chronic Kidney Disease in Primary Care","author":"Department of Veterans Affairs, and Health Affairs, Department of Defense","year":"2014","unstructured":"VA\/DoD Clinical Practice Guideline for the Management of Chronic Kidney Disease in Primary Care. Department of Veterans Affairs, and Health Affairs, Department of Defense. 2014."},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1177\/1536867x1201200209"},{"key":"e_1_3_3_16_2","first-page":"1","article-title":"National Center for Health Statistics guidelines for analysis of trends.","volume":"2","author":"Ingram DD","year":"2018","unstructured":"Ingram, DD, Malec, DJ, Makuc, DM, Kruszon-Moran, D, Gindi, RM, Albert, M, Beresovsky, V, Hamilton, BE, Holmes, J, Schiller, J, et al. National Center for Health Statistics guidelines for analysis of trends. Vital Health Stat 2. 2018;2:1\u201371.","journal-title":"Vital Health Stat 2"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2014.8012"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2018.05.026"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1991.03460040065031"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-159-4-201308200-00004"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000199667.30253.b7"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1001286"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1511939"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.030848"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-2047"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.0051"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.17821"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1159\/000531102"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2018.4749"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2210639"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2110730"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-141-12-200412210-00010"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.9.1041"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.168.9.950"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01890-4"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.025322"},{"key":"e_1_3_3_37_2","unstructured":"Honoring our PACT Act of 2022. (2021-2022) ed; 2022."},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.4338\/ACI-2016-10-RA-0184"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.123.21523","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T16:41:34Z","timestamp":1750869694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.123.21523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.123.21523"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.123.21523","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"2023-05-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}